496 related articles for article (PubMed ID: 11396162)
21. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy.
Walker J; Martin C; Callaghan R
Eur J Cancer; 2004 Mar; 40(4):594-605. PubMed ID: 14962729
[TBL] [Abstract][Full Text] [Related]
22. Mode of action of torilin in multidrug-resistant cancer cell lines.
Kim SE; Hong YS; Kim YC; Lee JJ
Planta Med; 1998 May; 64(4):335-8. PubMed ID: 9619116
[TBL] [Abstract][Full Text] [Related]
23. CJY, an isoflavone, reverses P-glycoprotein-mediated multidrug-resistance in doxorubicin-resistant human myelogenous leukaemia (K562/DOX) cells.
Ji BS; He L
J Pharm Pharmacol; 2007 Jul; 59(7):1011-5. PubMed ID: 17637197
[TBL] [Abstract][Full Text] [Related]
24. Selective modulation of P-glycoprotein-mediated drug resistance.
Bebawy M; Morris MB; Roufogalis BD
Br J Cancer; 2001 Dec; 85(12):1998-2003. PubMed ID: 11747345
[TBL] [Abstract][Full Text] [Related]
25. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
26. Acridones circumvent P-glycoprotein-associated multidrug resistance (MDR) in cancer cells.
Gopinath VS; Thimmaiah P; Thimmaiah KN
Bioorg Med Chem; 2008 Jan; 16(1):474-87. PubMed ID: 17933543
[TBL] [Abstract][Full Text] [Related]
27. Lobeline, a piperidine alkaloid from Lobelia can reverse P-gp dependent multidrug resistance in tumor cells.
Ma Y; Wink M
Phytomedicine; 2008 Sep; 15(9):754-8. PubMed ID: 18222670
[TBL] [Abstract][Full Text] [Related]
28. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
Peer D; Dekel Y; Melikhov D; Margalit R
Cancer Res; 2004 Oct; 64(20):7562-9. PubMed ID: 15492283
[TBL] [Abstract][Full Text] [Related]
29. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
Chavanpatil MD; Patil Y; Panyam J
Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
[TBL] [Abstract][Full Text] [Related]
30. Cepharanthin, a multidrug resistant modifier, is a substrate for P-glycoprotein.
Hirai M; Tanaka K; Shimizu T; Tanigawara Y; Yasuhara M; Hori R; Kakehi Y; Yoshida O; Ueda K; Komano T
J Pharmacol Exp Ther; 1995 Oct; 275(1):73-8. PubMed ID: 7562598
[TBL] [Abstract][Full Text] [Related]
31. The effects of cannabinoids on P-glycoprotein transport and expression in multidrug resistant cells.
Holland ML; Panetta JA; Hoskins JM; Bebawy M; Roufogalis BD; Allen JD; Arnold JC
Biochem Pharmacol; 2006 Apr; 71(8):1146-54. PubMed ID: 16458258
[TBL] [Abstract][Full Text] [Related]
32. P-glycoprotein enhances TRAIL-triggered apoptosis in multidrug resistant cancer cells by interacting with the death receptor DR5.
Park SJ; Wu CH; Choi MR; Najafi F; Emami A; Safa AR
Biochem Pharmacol; 2006 Jul; 72(3):293-307. PubMed ID: 16753135
[TBL] [Abstract][Full Text] [Related]
33. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
Breier A; Drobná Z; Barancík M
Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
[TBL] [Abstract][Full Text] [Related]
34. Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate.
Wang C; Zhang JX; Shen XL; Wan CK; Tse AK; Fong WF
Biochem Pharmacol; 2004 Sep; 68(5):843-55. PubMed ID: 15294447
[TBL] [Abstract][Full Text] [Related]
35. Levistolide A overcomes P-glycoprotein-mediated drug resistance in human breast carcinoma cells.
Chen F; Wang T; Wang J; Wang ZQ; Qian M
Acta Pharmacol Sin; 2008 Apr; 29(4):458-64. PubMed ID: 18358092
[TBL] [Abstract][Full Text] [Related]
36. Induction of the multidrug-transporter P-glycoprotein by 3'-azido-3'-deoxythymidine (AZT) treatment in tumor cell lines.
Signoretti C; Romagnoli G; Turriziani O; Antonelli G; Dianzani F; Cianfriglia M
J Exp Clin Cancer Res; 1997 Mar; 16(1):29-32. PubMed ID: 9148857
[TBL] [Abstract][Full Text] [Related]
37. Reversal effect of substituted 1,3-dimethyl-1H-quinoxalin-2-ones on multidrug resistance in adriamycin-resistant K562/A02 cells.
Sun LR; Li X; Cheng YN; Yuan HY; Chen MH; Tang W; Ward SG; Qu XJ
Biomed Pharmacother; 2009 Mar; 63(3):202-8. PubMed ID: 18818047
[TBL] [Abstract][Full Text] [Related]
38. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
Aftab DT; Yang JM; Hait WN
Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466
[TBL] [Abstract][Full Text] [Related]
39. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers.
Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS
Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]